Avenue Therapeutics Inc (ATXI)
0.1157
+0.02
(+22.69%)
USD |
NASDAQ |
Apr 25, 16:00
0.108
-0.01
(-6.66%)
After-Hours: 20:00
Avenue Therapeutics Enterprise Value: 1.463M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.463M |
| April 23, 2024 | 3.220M |
| April 22, 2024 | 3.047M |
| April 19, 2024 | 3.043M |
| April 18, 2024 | 3.246M |
| April 17, 2024 | 3.269M |
| April 16, 2024 | 3.109M |
| April 15, 2024 | 2.822M |
| April 12, 2024 | 3.286M |
| April 11, 2024 | 3.539M |
| April 10, 2024 | 3.910M |
| April 09, 2024 | 3.791M |
| April 08, 2024 | 4.083M |
| April 05, 2024 | 3.875M |
| April 04, 2024 | 3.795M |
| April 03, 2024 | 3.884M |
| April 02, 2024 | 3.928M |
| April 01, 2024 | 3.932M |
| March 28, 2024 | 3.818M |
| March 27, 2024 | 4.043M |
| March 26, 2024 | 3.972M |
| March 25, 2024 | 4.149M |
| March 22, 2024 | 3.981M |
| March 21, 2024 | 4.296M |
| March 20, 2024 | 4.300M |
| Date | Value |
|---|---|
| March 19, 2024 | 4.371M |
| March 18, 2024 | 4.371M |
| March 15, 2024 | 4.260M |
| March 14, 2024 | 4.149M |
| March 13, 2024 | 4.765M |
| March 12, 2024 | 5.030M |
| March 11, 2024 | 4.459M |
| March 08, 2024 | 5.787M |
| March 07, 2024 | 5.008M |
| March 06, 2024 | 4.676M |
| March 05, 2024 | 4.725M |
| March 04, 2024 | 4.313M |
| March 01, 2024 | 4.260M |
| February 29, 2024 | 2.948M |
| February 28, 2024 | 2.944M |
| February 27, 2024 | 3.053M |
| February 26, 2024 | 2.773M |
| February 23, 2024 | 2.307M |
| February 22, 2024 | 2.594M |
| February 21, 2024 | 2.862M |
| February 20, 2024 | 2.848M |
| February 16, 2024 | 2.728M |
| February 15, 2024 | 2.784M |
| February 14, 2024 | 2.750M |
| February 13, 2024 | 2.683M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.288M
Minimum
Apr 24 2023
196.18M
Maximum
Sep 14 2020
51.68M
Average
24.79M
Median
Enterprise Value Benchmarks
| Fortress Biotech Inc | -3.595M |
| NovaBay Pharmaceuticals Inc | 2.284M |
| Palatin Technologies Inc | 18.43M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.64M |
| Total Expenses (Quarterly) | 2.119M |
| EPS Diluted (Quarterly) | 0.025 |
| Earnings Yield | -3.29K% |